Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
13,772,069
-
Share change
-
-27,944
-
Total reported value
-
$396,081,310
-
Price per share
-
$28.76
-
Number of holders
-
51
-
Value change
-
-$362,739
-
Number of buys
-
40
-
Number of sells
-
10
Institutional Holders of SATSUMA PHARMACEUTICALS INC - COM (STSA) as of Q2 2020
As of 30 Jun 2020,
SATSUMA PHARMACEUTICALS INC - COM (STSA) was held by
51 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
13,772,069 shares.
The largest 10 holders included
RA CAPITAL MANAGEMENT, L.P., TPG Group Holdings (SBS) Advisors, Inc., WELLINGTON MANAGEMENT GROUP LLP, CITADEL ADVISORS LLC, EVENTIDE ASSET MANAGEMENT, LLC, Cormorant Asset Management, LP, BlackRock Inc., VANGUARD GROUP INC, Ghost Tree Capital, LLC, and Ikarian Capital, LLC.
This page lists
51
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.